Lejla Mahmutović

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Epithelial Mesenchymal Transition

Molecular Docking

Immune Response

Chronic Myeloid Leukemia

Top Venues

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Esma Bilajac, Lejla Mahmutović, Una Glamoclija, Amar Osmanović, Altijana Hromić-Jahjefendić, Murtaza M Tambuwala, Mirza Suljagić
Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines. Metabolites 13 (1) (2022)
Esma Bilajac, Lejla Mahmutović, Kenneth Lundstrom, Una Glamočlija, Jasmin Šutković, Abas Sezer, Altijana Hromić-Jahjefendić
Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. Viruses 14 (10) (2022)
Esma Bilajac, Lejla Mahmutović, Una Glamoclija, Amar Osmanović, Altijana Hromić-Jahjefendić, Murtaza M Tambuwala, Mirza Suljagić
Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines. Metabolites 13 (1) (2022)
Esma Bilajac, Lejla Mahmutović, Una Glamoclija, Amar Osmanović, Altijana Hromić-Jahjefendić, Murtaza M Tambuwala, Mirza Suljagić
Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines. Metabolites 13 (1) (2022)
Esma Bilajac, Lejla Mahmutović, Una Glamoclija, Amar Osmanović, Altijana Hromić-Jahjefendić, Murtaza M Tambuwala, Mirza Suljagić
Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines. Metabolites 13 (1) (2022)